Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity
Anne-Laure Kaminsky, Abdou Y. Omorou, Marc Soudant, S. Pittion‐Vouyovitch, Maud Michaud, René Anxionnat, Françis Guillemin, Marc Debouverie, Guillaume Mathey
Topics & Concepts
MedicineDiscontinuationMultiple sclerosisInternal medicineHazard ratioProportional hazards modelNeurologyPropensity score matchingDiseasePopulationCentral nervous system diseaseConfidence intervalImmunologyPsychiatryEnvironmental healthMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersAmyotrophic Lateral Sclerosis Research